Injectables - Plastic Surgery Internal

More documents

Recommendations

Info

Reconstr Surg 2009;124:1328–1329. 114. Lemperle G, de Fazio S, Nicolau P. Artefill: A thirdgeneration permanent dermal filler and tissue stimulator. Clin Plast Surg 2006;33:551–565. 115. Ha RY, Nojima K, Adams WP Jr, Brown SA. Analysis of facial skin thickness: Defining the relative thickness index. Plast Reconstr Surg 2005;115:1769–1773. 116. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg 2006;118[suppl 3]:92S–107S. 117. Arlette JP, Trotter MJ. Anatomic location of hyaluronic acid filler material injected into nasolabial fold: A histologic study. Dermatol Surg 2008;34[suppl 1]:S56–S62. 118. Rohrich RJ, Ghavami A, Crosby MA. The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: Review and technical considerations. Plast Reconstr Surg 2007;120[suppl 6]:41S–54S. 119. Glogau RG, Kane MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg 2008;34[suppl 1]:S105–S109. 120. Coleman KR, Carruthers J. Combination therapy with Botox and fillers: The new rejuvenation paradigm. Dermatol Ther 2006;19:177–188. 121. Rohrich RJ, Pessa JE. The fat compartments of the face: Anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg 2007;119:2219–2227. 122. Gelfer A, Carruthers A, Carruthers J, Jang F, Bernstein SC. The natural history of polymethylmethacrylate microspheres granulomas. Dermatol Surg 2007;33:614–620. 123. Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: Treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg 2003;29:802–809. 124. Alam M, Dover JS. Management of complications and sequelae with temporary injectable fillers. Plast Reconstr Surg 2007;120[suppl 6]:98S–105S. 125. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: Review. Dermatol Surg 2005;31:1616–1625. 126. Andre P, Lowe NJ, Parc A, Clerici TH, Zimmerman U. Adverse reactions to dermal fillers: A review of European experiences. J Cosmet Laser Ther 2005;7:171–176. 127. Parada MB, Michalany NS, Hassun KM, Bagatin E, SRPS • Volume 10 • Issue 28 • 2010 Talarico S. A histologic study of adverse effects of different cosmetic skin fillers. Skinmed 2005;4:345–349. 128. Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann- Klein M, Zimmermann U, Duffy DM. Foreign body granulomas after all injectable dermal fillers: Part 1. Possible causes. Plast Reconstr Surg 2009;123:1842–1863. 129. Lemperle G, Gauthier-Hazan N. Foreign body granulomas after all injectable dermal fillers: Part 2. Treatment options. Plast Reconstr Surg 2009;123:1864–1873. 130. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg 2003;27: 354–366. 131. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005;29:34–48. 132. Rohrich RJ, Monheit GD, Nguyen AT, Brown SA, Fagien S. Soft tissue filler complications: The important role of biofilms. Plast Reconstr Surg 2010;125:1250–1256. 133. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003;29:588–595. 134. Mullins RJ, Richards C, Walker T. Allergic reactions to oral, surgical and topical bovine collagen: Anaphylactic risk for surgeons. Aust N Z J Ophthalmol 1996;24:257–260. 135. Narins RS, Jewell M, Rubin M, Cohen J, Strobos J. Clinical conference: Management of rare events following dermal fillers: Focal necrosis and angry red bumps. Dermatol Surg 2006;32:426–434. 136. Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: Protocol for prevention and treatment after use of dermal fillers. Dermatol Surg 2006;32:276–281. 137. McCleve DE, Goldstein JC. Blindness secondary to injections in the nose, mouth, and face: Cause and prevention. Ear Nose Throat J 1995;74:182–188. 138. Sclafani AP, Fagien S. Treatment of injectable soft tissue filler complications. Dermatol Surg 2009;35[suppl 2]: 1672–1680. 139. Cohen JL, Brown MR. Anatomic considerations for soft tissue augmentation of the face. J Drugs Dermatol 2009;8:13–16. 140. Hirsch RJ, Cohen JL, Carruthers JD. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg 2007;33:357–360. 23
SRPS • Volume 10 • Issue 28 • 2010 141. Hirsch RJ, Brody HJ, Carruthers JD. Hyaluronidase in the office: A necessity for every dermasurgeon that injects hyaluronic acid. J Cosmet Laser Ther 2007;9:182–185. 142. Jones DH, Carruthers A, Orentreich D, Brody HJ, Lai MY, Azen S, Van Dyke GS. Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: An open pilot trial. Dermatol Surg 2004;30:1279–1286. 143. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999;284:1318–1322. 144. Wolcott RD, Ehrlich GD. Biofilms and chronic infections. JAMA 2008;299:2682–2684. 145. Bjarnsholt T, Tolker-Nielsen T, Givskov M, Janssen M, Christensen LH. Detection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg 2009;35[suppl 2]:1620–1624. 146. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, Mandrekar JN, Cockerill FR, Steckelberg JM, Greenleaf JF, Patel R. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007;357:654–663. 147. Hoffmann N, Lee B, Hentzer M, Rasmussen TB, Song Z, Johansen HK, Givskov M, Høiby N. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth- 24 phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob Agents Chemother 2007;51:3677–3687. 148. Lambros V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg 2004;114:277. 149. Cassuto D, Marangoni O, De Santis G, Christensen L. Advanced laser techniques for filler-induced complications. Dermatol Surg 2009;35[suppl 2]:1689–1695. 150. Reisman NR. Ethics, legal issues, and consent for fillers. Clin Plast Surg 2006;33:505–510. 151. American Society of Plastic Surgeons, American Society for Aesthetic Plastic Surgery. Injectables and fillers: Legal and regulatory risk management issues. Plast Reconstr Surg 2006;118[suppl 3]:129S–132S. 152. American Society of Plastic Surgeons, American Society for Aesthetic Plastic Surgery. Joint ASPS & ASAPS Guiding Principles: Supervision of Non-Physician Personnel in Medical Spas and Physician Offices. Arlington Heights: ASPS Executive Committee; New York: ASAPS Executive Committee; 2006. http://www.plasticsurgery.org/Documents/Media/Joint- ASPS-and-ASAPS-Guiding-Principles-Supervision-of-Non- Physician-Personnel-in-Medical-Spas-and-Physician-Offices. pdf Last accessed, June 30, 2010.
Page 1 and 2: SRPS SELECTED READINGS IN PLASTIC S
Page 3 and 4: Editor-in-Chief Editor Emeritus Con
Page 5 and 6: SRPS • Volume 10 • Issue 28 •
Page 25: SRPS • Volume 10 • Issue 28 •
Page 29 and 30: Order Today: (800) 818-7243 (US & C
Page 31: extends thanks to for their support

Injectables - Plastic Surgery Internal

Create successful ePaper yourself

Delete template?

Save as template?